SSTR2 and neoplasm: This pilot study was designed to test the following assumptions: (i) SSTR2 expression in SI-NETs correlates among a patient’s lesions, i.e., the presence of one tumor with a low SSTR2 expression indicates that the patient could have other lesions with a low SSTR2 expression.